Literature DB >> 17391296

Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.

Lucinei Roberto de Oliveira1, Alfredo Ribeiro-Silva, Sérgio Zucoloto.   

Abstract

BACKGROUND: The role of p53 and p63 proteins in the prognosis of oral squamous cell carcinoma (OSCC) is still debatable. Our aim here was to investigate the relationship between the immunoexpression of these proteins with some clinicopathologic parameters of prognostic significance in OSCC.
METHODS: Formalin-fixed paraffin-embedded sections from 106 patients were used for study together with the following data: primary site, histologic differentiation, recurrences, metastasis, disease-free survival and overall survival (OS).
RESULTS: In OSCCs, the positive rate for p63 protein immunoexpression (87.8%) was higher than p53 (52.8%). p53 expression correlated with metastasis. Tumors negative for p53 and with strong intensity for p63 expression had a significantly higher OS.
CONCLUSIONS: p53 overexpression is associated with a larger number of metastases and is correlated with a poor outcome as well as decreased intensity in p63 immunoexpression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391296     DOI: 10.1111/j.1600-0714.2007.00517.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  15 in total

Review 1.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

2.  p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.

Authors:  M Re; A Zizzi; L Ferrante; D Stramazzotti; G Goteri; F M Gioacchini; F Olivieri; G Magliulo; C Rubini
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-09       Impact factor: 2.503

3.  Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia.

Authors:  Mark C Pierce; Richard A Schwarz; Vijayashree S Bhattar; Sharon Mondrik; Michelle D Williams; J Jack Lee; Rebecca Richards-Kortum; Ann M Gillenwater
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-02

4.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

5.  P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region.

Authors:  Alexander Gröbe; Henning Hanken; Ahmed Al-Dam; Georg Cachovan; Ralf Smeets; Antje Krohn; Till Clauditz; Tobias Grob; Ronald Simon; Guido Sauter; Lan Kluwe; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-02-13       Impact factor: 3.573

6.  Histological significance of p53 gene expression in squamous cell carcinoma of the buccal mucosa.

Authors:  Bhushan V Jayade; Kishore Bhat; B R Patil; Ramakant Nayak; Aswari Sant
Journal:  J Maxillofac Oral Surg       Date:  2009-11-21

7.  Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.

Authors:  Zehang Zhuang; Nan Xie; Jing Hu; Pei Yu; Cheng Wang; Xingxue Hu; Xiaozhe Han; Jinsong Hou; Hongzhang Huang; Xiqiang Liu
Journal:  Oncotarget       Date:  2017-03-28

8.  Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia.

Authors:  Sunit B Patel; Bhari S Manjunatha; Vandana Shah; Nishit Soni; Rakesh Sutariya
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-10-26

9.  The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma.

Authors:  Lan Yang; Youyuan Wang; Lvhua Guo; Liping Wang; Weiliang Chen; Bin Shi
Journal:  Biomed Res Int       Date:  2015-10-07       Impact factor: 3.411

10.  P63 and Ki-67 Expression in Dentigerous Cyst and Ameloblastomas.

Authors:  Zohreh Jaafari-Ashkavandi; Bita Geramizadeh; Mohammad Ali Ranjbar
Journal:  J Dent (Shiraz)       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.